Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Jan Marsal, Manuel Barreiro–de Acosta, Irina Blumenstein, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Antibiotics influence the risk of anti-drug antibody formation during anti-TNF therapy in Chinese inflammatory bowel disease patients
Meng Sun, Jingyi Ju, Hongzhen Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
A Bottom-Up Liquid Chromatography–Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Infliximab: Method Development, Comparison With 2 Enzyme-Linked Immunosorbent Assay Methods, and Evaluation of Anti-Drug Antibody Interference
Sangmi Kim, Hyeonju Oh, Sung Noh Hong, et al.
Archives of Pathology & Laboratory Medicine (2024)
Open Access | Times Cited: 1
Advanced combination therapy: is it the best way to break the therapeutic ceiling?
Panu Wetwittayakhlang, Péter L. Lakatos
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Reprogramming of Treg cell-derived small extracellular vesicles effectively prevents intestinal inflammation from PANoptosis by blocking mitochondrial oxidative stress
Wenbin Gong, Zhenni Liu, Yuqiu Wang, et al.
Trends in biotechnology (2024)
Closed Access | Times Cited: 1
Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD
Kush Fansiwala, Jenny Sauk
Digestive Diseases and Sciences (2024)
Open Access | Times Cited: 1
Molecular Imaging
Raja Atreya, Timo Räth, Markus F. Neurath
Gastrointestinal Endoscopy Clinics of North America (2024) Vol. 35, Iss. 1, pp. 255-263
Closed Access
Biological Response of Treatment with Saffron Petal Extract on Cytokine-Induced Oxidative Stress and Inflammation in the Caco-2/Human Leukemia Monocytic Co-Culture Model
Federica De Cecco, Sara Franceschelli, Valeria Panella, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1257-1257
Open Access
Vagal stimulation ameliorates murine colitis by regulating SUMOylation
Ayman Youssef, Ata Ur Rehman, Mohamed Elebasy, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 774
Closed Access
Predictors of Relapse among Inflammatory Bowel Disease Patients on Biological Treatment in Upper Egypt
Hossam Mahmoud Abdelwahab, Mohamed Ashraf, Rania Elsaghier, et al.
The Egyptian Journal of Hospital Medicine (2024) Vol. 94, Iss. 1, pp. 231-238
Open Access
Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: An open-label, proof-of concept study
Kenji Suzuki, Yukinori Sameshima, Junji Yokoyama, et al.
Research Square (Research Square) (2024)
Open Access
A Retrospective Observational Study of Patterns of Biologic Drug Change in Inflammatory Bowel Disease
Mahmoud Mosli
Inflammatory Intestinal Diseases (2024)
Open Access
Evaluating the pharmacokinetics of upadacitinib for the treatment of moderate-to-severe Crohn’s disease
Ilaria Faggiani, Ferdinando D’Amico, Francesca Futura Bernardi, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 297-305
Closed Access
How close are we to a success stratification tool for improving biological therapy in ulcerative colitis?
Panu Wetwittayakhlang, Gynter Kotrri, Talat Bessissow, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 433-441
Closed Access
Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease
M. Wolf, Julian Lange, Dirk Benndorf, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ultrasound transmural healing correlates with higher adalimumab drug concentration in Crohn's disease only in the short-term.
José Ramón Lorente, José María Rubio Paredes, Pilar Llopis, et al.
Revista Española de Enfermedades Digestivas (2024)
Open Access
Cystathionine Gamma-Lyase Regulates TNF-α-Mediated Injury Response in Human Colonic Epithelial Cells and Colonoids
Francisco Arroyo Almenas, Gábor Törő, Peter Szaniszlo, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1067-1067
Open Access
Colon‐adhesive poly(maleic anhydride)‐sirolimus conjugate alleviates local colitis inflammation
Sang‐Hun Choi, Soo‐Hyang Chi, Y.B. Park, et al.
Journal of Applied Polymer Science (2024)
Closed Access
Identification and Validation of Biomarkers to Predict Early Diagnosis of Inflammatory Bowel Disease and Its Progression to Colorectal Cancer
Farhat Aziz Khan, Naaziyah Abdulla, Thea-Leonie du Plessis, et al.
Biochemical Genetics (2024)
Open Access
Crohn’s disease management: translating STRIDE-II for UK clinical practice
Karen Kemp, Mark Samaan, Ajay Verma, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Eleven Grand Challenges for Inflammatory Bowel Disease Genetics and Genomics
Greg Gibson, John D. Rioux, Judy H. Cho, et al.
Inflammatory Bowel Diseases (2024) Vol. 31, Iss. 1, pp. 272-284
Closed Access
Editorial: LAG‐3‐depleting monoclonal antibody: a potential treatment for patients with ulcerative colitis?
Triana Lobatón, Marie Truyens
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 3, pp. 359-360
Open Access | Times Cited: 1
Discovering the Nutrition-Microbiota Interplay in Inflammatory Bowel Disease: Are We There Yet?
Marilina Florio, Lucilla Crudele, Antonio Moschetta, et al.
Endocrinology (2023), pp. 1-39
Closed Access
Development of a high-throughput barrier function assay using primary human gut organoids
Charles Wright, Naomi Li, Lynsey Shaffer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Previous Page - Page 2

Scroll to top